Review of Norwegian strategy on noncommunicable diseases

The purpose of this mid-term review is to assess whether and to what extent the Norad and MFA noncommunicable disease (NCD) strategy is starting to take root and to make recommendations regarding the overall programme going forward. The review will also consider whether adjustments to ongoing
investments should be made to bring them into line with Norwegian priorities and policies during the final two years of the strategic period (2023-2024). The primary objective of the review is to assess whether the overall composition of the portfolio and selection of implementing partners are relevant, coherent and targeted in line with the NCD development programme.

The supplementary objectives of the review are to:
- Identify how and to what extent individual elements of the portfolio of implementing partners have been particularly relevant.
- Take note of information available about what is reported to be going well as well as challenges among implementing partners and in countries (Ghana and Nepal).

The review will gather evidence that covers the assessment of Norad and the Ministry of Foreign Affairs NCD programmes and areas of priority with an aim to include recommendations and suggestions of areas for continued investments, possible scaling and, if relevant, new priorities.